Q3 2021 Arbutus Biopharma Corp Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Pharmaceutical Biopharma Corporation 2021 Third Quarter Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to Lisa Caperelli, Vice President of Investor Relations. Please go ahead.
Thank you, Angie. Good morning, everyone, and thank you for joining Arbutus' third quarter financial and business update call. Joining me today from the Arbutus executive team are Bill Collier, President and Chief Executive Officer; David Hastings, Chief Financial Officer. Dr. Gaston Picchio, Chief Development Officer; and Dr. Mike Sofia, Chief Scientific Officer.
Bill will begin with a review of recent accomplishments and clinical developments, followed by Mike Sofia, who will provide an update on our research efforts with an oral PD-L1 inhibitor. Dave Hastings will then provide a review of the company's third quarter financial results.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
